# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-021034
Filing Date
2024-05-22
Accepted
2024-05-22 16:45:38
Documents
6
Period of Report
2024-05-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 876551
2 |  | def14a_001.jpg | GRAPHIC | 3857
3 |  | def14a_003.jpg | GRAPHIC | 28232
4 |  | def14a_004.jpg | GRAPHIC | 28061
5 |  | proxycard_001.jpg | GRAPHIC | 757460
6 |  | proxycard_002.jpg | GRAPHIC | 310693
| Complete submission text file | 0001493152-24-021034.txt |  | 2432128

Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33672 | Film No.: 24974007
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)